Treatment recommendations evolving from critical appraisal are not only based on levels of evidence, but the risk benefit ratio and cost.
由严格评价得出的治疗建议不能仅仅基于证据的等级,还应考虑风险效益比和费用问题。
This phased approach means that the cost-to-benefit ratio isn't rosy either, and unless the head team can deploy aggressively and successfully, the project is at risk of being shut down.
分阶段方案意味着效益成本比也并不乐观,除非主管团队能积极推广并获得成功,否则项目也存在着关张的风险。
Peters et al suggest that the procedure should be reserved only for research protocols with rigorous analysis of the risk-benefit ratio.
Peters等人建议,此手术应限制在研究框架内,需严格分析其风险-效益比。
应用推荐